Clinical trial
Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in Autosomal Dominant Polycystic Kidney Disease (ADPKD): The GeneQuest Study
NCT02112136 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in Autosomal Dominant Polycystic Kidney Disease (ADPKD): The GeneQuest Study
- Lead sponsor
- University Hospital, Brest
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2014
- Completion date
- December 12, 2020
- Enrollment
- 1,450 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal dominant polycystic kidney disease (adpkd)